Project
IFX-1-P2.5
Completed ยท 2020 until 2021
Peischl Riana, Neumann Thomas, Rubbert-Roth Andrea
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Completed
Start Date
2020
End Date
2021
Financing
Others
Study Design
This is a prospective, randomized, double-blind, double-dummy, active-controlled, multicenter, 2-part Phase 2 study. a total of 3 treatment groups will be investigated:
Group A: IFX-1 + reduced-dose GC
Group B: Placebo-IFX-1 + stadard-dose GC
Group C: IFX-1 + no GC
Brief description/objective
a randomized, double-blind, double-dummy, active-controlled, multicenter, 2-part Phase 2 study on replacement of steroids by IFX-1 in active granulomatosis with polyangiitis (GPA) and microscopic polyangitis (MPA)